Navigation Links
Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
Date:11/25/2008

People with chronic obstructive pulmonary disorder must weigh risks, benefits, experts say

TUESDAY, Nov. 25 (HealthDay News) -- A new review of existing data confirms that some common inhalers don't boost the life spans of people with the lung disease known as chronic obstructive pulmonary disease (COPD).

In fact, these medicines may even raise the risk of pneumonia in patients with COPD, the fourth biggest killer in the United States.

But patients shouldn't stop using the inhalers without consulting their doctors first, because the devices still provide benefit in some cases, said review lead author Dr. M. Bradley Drummond.

"It's about balancing the known benefits with potential risks," said Drummond, a fellow in the division of pulmonary and critical care medicine at Johns Hopkins University, Baltimore.

The study was published in the Nov. 26 issue of the Journal of the American Medical Association.

Chronic obstructive pulmonary disease -- which encompasses emphysema and chronic bronchitis -- follows heart disease, cancer and stroke as the leading cause of deaths among Americans, Drummond said. Symptoms include breathlessness, frequent wheezing and coughing. Treatment can ease symptoms, but there is no cure for COPD.

More than 90 percent of cases are related to smoking, Drummond said. Smoke causes abnormal inflammation in the lungs, which destroys the ends of the airways and makes it difficult for the body to extract the oxygen from the air around them, he said.

In many cases, patients can extend their lives by stopping smoking and breathing oxygen. Some turn to inhaled corticosteroids, which reduce inflammation by calming the immune system.

Inhaled corticosteroids, known by brand names such as Pulmicort, Azmacort and Flovent, are commonly used to treat lung conditions like asthma.

But research has suggested that the inhalers aren't right for all COPD patients. In the new review, Drummond and colleagues examined 11 studies and combined their results in a "meta analysis."

The researchers found no significant difference in the one-year death rate from research involving more than 4,600 patients who used the inhalers versus a similar number of patients who did not.

More patients were included in studies that examined the risk of pneumonia, however. The number of pneumonia of cases was about a third higher in those who used the inhalers compared to those who didn't.

A total of 777 of the 5,405 patients who used the inhalers developed pneumonia, compared to 561 of 5,371 patients who did not, the Johns Hopkins team noted.

Up to 15 million Americans currently have some form of COPD, Drummond said, "and it's estimated that about half of those use inhaled steroids. You're looking at six million people who may be exposed to this 34 percent increase in risk."

While there's "clearly a benefit in some patients" who report that they feel better while using inhalers, the drugs aren't for everyone, Drummond said.

It's not clear why the inhalers may boost the risks of pneumonia, he said, but they may suppress the immune system in the lungs.

Dr. Norman H. Edelman, chief medical officer of the American Lung Association, said the review reflects existing beliefs about the use of these devices

"We already have accepted that inhaled steroids increase the risk of pneumonia in COPD patients," he said. "All medication decisions involve a risk/benefit analysis. Doctors should keep the risk in mind and weigh it against actual benefits, always in full consultation with the patient, who should make the ultimate decision."

More information

There's more on COPD at the U.S. National Heart, Lung, and Blood Institute.



SOURCES: M. Bradley Drummond, M.D., fellow, division of pulmonary and critical care medicine, Johns Hopkins University, Baltimore; Norman Edelman, M.D., chief medical officer, American Lung Association, Stony Brook, N.Y.; Nov. 26, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study shows steroid therapies following transplant can be eliminated
2. Steroids aid recovery from pneumonia, UT Southwestern researchers say
3. Steroid treatment offers no benefit in preemies, Hopkins Childrens study suggests
4. Changes in sex steroids associated with menopause
5. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
6. Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids
7. I Play Clean(TM) and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use
8. Corticosteroids of Little Use Against Childhood Meningitis
9. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
10. New steroid test uses oil exploration technique
11. Youth Impacted By Recent Mitchell Report on Major League Baseball Steroid Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
(Date:6/23/2016)... Research and Markets has announced ... Analysis (United States, China, Japan, Brazil, United Kingdom, Germany, ... offering. Surgical Procedure ... planners, provides surgical procedure volume data in a geographic ... in-depth analysis of growth drivers and inhibitors, including world ...
Breaking Medicine Technology: